Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study

OBJECTIVE: To evaluate upadacitinib efficacy and safety dose response in Japanese patients with active RA and an inadequate response to conventional synthetic DMARDs (csDMARDs). METHODS: This was a multicentre, phase IIb/III, dose-ranging study conducted in Japan, in which patients on previously sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kameda, Hideto, Takeuchi, Tsutomu, Yamaoka, Kunihiro, Oribe, Motohiro, Kawano, Mitsuhiro, Zhou, Yijie, Othman, Ahmed A, Pangan, Aileen L, Kitamura, Susumu, Meerwein, Sebastian, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590414/
https://www.ncbi.nlm.nih.gov/pubmed/32277824
http://dx.doi.org/10.1093/rheumatology/keaa084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590414/
https://www.ncbi.nlm.nih.gov/pubmed/32277824
http://dx.doi.org/10.1093/rheumatology/keaa084

Ejemplares similares